LogicBio Therapeutics (LOGC) Misses Q3 EPS by 7c
Tweet
Share
E-mailGet Alerts LOGC Hot Sheet
Price: $7.06 --0%
EPS Growth %: +82.6%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: +82.6%
Financial Fact:
Loss per share (in dollars per share): -0.01
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
LogicBio Therapeutics (NASDAQ: LOGC) reported Q3 EPS of ($0.07).
For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trex (TREX) Reiterated at Hold by Benchmark as Partnership Agreement Announced
- Hut 8 Mining Corp. (HUT) PT Raised to $165 at Benchmark as Numbers Move Quickly
- Wells Fargo (WFC) Tops Q2 EPS by 28c, Beats on Revene
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
